Further, this result demonstrates Pyrvinium's growth inhibitory effect on CRC cells containing mutant p53, RAS and overexpressed MYC[43], all of which are present within the various CRC cell lines used (Table 1) and commonly found in FAP-associated CRC [44]–[47]. This evidence concerns the gene TP53 and colorectal carcinoma.